Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Enkephalin levels and the number of neuropeptide Y-containing interneurons in the hippocampus are decreased in female cannabinoid-receptor 1 knock-out mice.

Rogers SA, Kempen TA, Pickel VM, Milner TA.

Neurosci Lett. 2016 May 4;620:97-103. doi: 10.1016/j.neulet.2016.03.030. Epub 2016 Mar 21.

PMID:
27012427
2.

Functional Connectivity Disruption in Neonates with Prenatal Marijuana Exposure.

Grewen K, Salzwedel AP, Gao W.

Front Hum Neurosci. 2015 Nov 4;9:601. doi: 10.3389/fnhum.2015.00601. eCollection 2015.

3.

Epigenetic Effects of Cannabis Exposure.

Szutorisz H, Hurd YL.

Biol Psychiatry. 2016 Apr 1;79(7):586-94. doi: 10.1016/j.biopsych.2015.09.014. Epub 2015 Nov 3. Review.

PMID:
26546076
4.

Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.

Maccarrone M, Guzmán M, Mackie K, Doherty P, Harkany T.

Nat Rev Neurosci. 2014 Dec;15(12):786-801. doi: 10.1038/nrn3846. Review.

5.

Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Ross EJ, Graham DL, Money KM, Stanwood GD.

Neuropsychopharmacology. 2015 Jan;40(1):61-87. doi: 10.1038/npp.2014.147. Epub 2014 Jun 18. Review.

6.

Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.

Tortoriello G, Morris CV, Alpar A, Fuzik J, Shirran SL, Calvigioni D, Keimpema E, Botting CH, Reinecke K, Herdegen T, Courtney M, Hurd YL, Harkany T.

EMBO J. 2014 Apr 1;33(7):668-85. doi: 10.1002/embj.201386035. Epub 2014 Jan 27.

7.

Female adolescent exposure to cannabinoids causes transgenerational effects on morphine sensitization in female offspring in the absence of in utero exposure.

Vassoler FM, Johnson NL, Byrnes EM.

J Psychopharmacol. 2013 Nov;27(11):1015-22. doi: 10.1177/0269881113503504. Epub 2013 Sep 18.

8.

Trajectory of adolescent cannabis use on addiction vulnerability.

Hurd YL, Michaelides M, Miller ML, Jutras-Aswad D.

Neuropharmacology. 2014 Jan;76 Pt B:416-24. doi: 10.1016/j.neuropharm.2013.07.028. Epub 2013 Aug 14.

9.

ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers.

Sillivan SE, Whittard JD, Jacobs MM, Ren Y, Mazloom AR, Caputi FF, Horvath M, Keller E, Ma'ayan A, Pan YX, Chiang LW, Hurd YL.

Biol Psychiatry. 2013 Oct 1;74(7):511-9. doi: 10.1016/j.biopsych.2013.04.012. Epub 2013 May 20.

10.

Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.

Farid WO, Lawrence AJ, Krstew EV, Tait RJ, Hulse GK, Dunlop SA.

PLoS One. 2012;7(12):e52812. doi: 10.1371/journal.pone.0052812. Epub 2012 Dec 26.

11.

Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia.

Gleason KA, Birnbaum SG, Shukla A, Ghose S.

Transl Psychiatry. 2012 Nov 27;2:e199. doi: 10.1038/tp.2012.122.

12.

Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization.

Psychoyos D, Vinod KY.

Drug Test Anal. 2013 Jan;5(1):27-45. doi: 10.1002/dta.1390. Epub 2012 Aug 13. Review.

13.

Proenkephalin mediates the enduring effects of adolescent cannabis exposure associated with adult opiate vulnerability.

Tomasiewicz HC, Jacobs MM, Wilkinson MB, Wilson SP, Nestler EJ, Hurd YL.

Biol Psychiatry. 2012 Nov 15;72(10):803-10. doi: 10.1016/j.biopsych.2012.04.026. Epub 2012 Jun 8.

14.

Parenteral Pethidine for labour pain relief and substance use disorder: 20-year follow-up cohort study in offspring.

Pereira RR, Kanhai H, Rosendaal F, van Dommelen P, Swaab D, Rodrigues Pereira E, van de Wetering B.

BMJ Open. 2012 May 30;2(3). pii: e000719. doi: 10.1136/bmjopen-2011-000719. Print 2012.

15.
16.

Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment.

Morris CV, DiNieri JA, Szutorisz H, Hurd YL.

Eur J Neurosci. 2011 Nov;34(10):1574-83. doi: 10.1111/j.1460-9568.2011.07884.x. Review.

17.

Prenatal tetrahydrocannabinol (THC) alters cognitive function and amphetamine response from weaning to adulthood in the rat.

Silva L, Zhao N, Popp S, Dow-Edwards D.

Neurotoxicol Teratol. 2012 Jan-Feb;34(1):63-71. doi: 10.1016/j.ntt.2011.10.006. Epub 2011 Nov 6.

18.

Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring.

DiNieri JA, Wang X, Szutorisz H, Spano SM, Kaur J, Casaccia P, Dow-Edwards D, Hurd YL.

Biol Psychiatry. 2011 Oct 15;70(8):763-9. doi: 10.1016/j.biopsych.2011.06.027. Epub 2011 Aug 5.

19.

Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections.

Wu CS, Zhu J, Wager-Miller J, Wang S, O'Leary D, Monory K, Lutz B, Mackie K, Lu HC.

Eur J Neurosci. 2010 Sep;32(5):693-706. doi: 10.1111/j.1460-9568.2010.07337.x. Epub 2010 Jul 28.

20.

Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens.

LaPlant Q, Vialou V, Covington HE 3rd, Dumitriu D, Feng J, Warren BL, Maze I, Dietz DM, Watts EL, Iñiguez SD, Koo JW, Mouzon E, Renthal W, Hollis F, Wang H, Noonan MA, Ren Y, Eisch AJ, Bolaños CA, Kabbaj M, Xiao G, Neve RL, Hurd YL, Oosting RS, Fan G, Morrison JH, Nestler EJ.

Nat Neurosci. 2010 Sep;13(9):1137-43. doi: 10.1038/nn.2619. Epub 2010 Aug 22.

Items per page

Supplemental Content

Write to the Help Desk